Matrix Therapy Company
in Regenerative Medecine

Home
Home
Home

Bringing
Matrix Therapy

from research
to patients

OTR3, the leading biotechnology company in Matrix Therapy, is fully committed to the development of new therapies based on the revolutionary RGTA® technology.

Home

The RGTA®

Technology

ReGeneraTing Agents (RGTA®) help restore the natural micro-environment around cells, promoting tissue regeneration.

Home
Home
Home

Research & Development

OTR3® is a biotechnology company with a strong lead in Research and Development, which excellence has been recognized by the European Commission (SME H2020 Instrument) and the French National Research Agency (ANR).

Our products

CACIPLIQ20®  is the first therapeutic product based on the innovative RGTA® technology.

Home

CACIPLIQ20 ®

This CE marked medical device promotes natural skin regeneration. CACIPLIQ20® is intended to improve the healing of chronic cutaneous ulcers.

Home
Home
Home
Home

© 2018 – OTR3 – All rights reserved
Design + Development by Popcorn 66

ADDRESS

4, rue Française
75001 Paris, France

© 2018 – OTR3 – All rights reserved
Design + Development by Popcorn 66